A hydroxamic acid that is N-hydroxyacrylamide which is substituted at position 3 by a 2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl group (the E isomer). An orally available pan-histone deacetylase inhibitor with demonstrated activity in the treatment of advanced solid tumours.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
CHEBI:24650CHEBI:36622CHEBI:50996CHEBI:78840| Molecular formula | C20H30N4O2 |
|---|---|
| Charge | 0 |
| Average mass | 358.486 Da |
| Monoisotopic mass | 358.23688 Da |
| Source | ChEBI |
| InChIKey | JHDKZFFAIZKUCU-ZRDIBKRKSA-N |
CCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC
InChI=1S/C20H30N4O2/c1-4-7-8-19-21-17-15-16(10-12-20(25)22-26)9-11-18(17)24(19)14-13-23(5-2)6-3/h9-12,15,26H,4-8,13-14H2,1-3H3,(H,22,25)/b12-10+
CHEBI:38068| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:95071 |
pracinostat | antibioticmech:chebi-0e7df505fd |
2026-08-30 |
Seeded from data/raw/ inventories (CHEBI)
Re-seeded from updated data/raw/ inventories
Re-seeded from updated data/raw/ inventories